Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Department of Biomedical Statistics and Bioinformatics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Transplantation. 2018 Apr;102(4):623-631. doi: 10.1097/TP.0000000000002047.
Portal hypertension (PHT) is defined as a portal venous pressure gradient (PVPG) exceeding 5 mm Hg, which results in severe clinical manifestations. However, the validity of intraoperative PVPG monitoring and the association between PHT and bacterial translocation after liver transplantation remain unclear.
In this retrospective study, 223 patients who underwent primary adult-to-adult living donor liver transplantation from 2008 to 2015 were divided into 2 groups based on the PVPG at the end of the operation: high PVPG (>5 mm Hg, n = 69) and low PVPG (≤5 mm Hg, n = 154). The clinical factors were compared between the groups, and the association between a high PVPG and posttransplant bacteremia/bacterial infections was investigated.
The high PVPG group had a significantly higher incidence of bacteremia (46% vs 24%, P < 0.001), higher 90-day mortality rate (20% vs 7%, P = 0.002), and poorer 1-year survival (71% vs 86%, P = 0.006). The high PVPG group had a particularly higher incidence of bacteremia caused by "gut bacteria" including Enterobacteriaceae, Bacteroides spp., and Enterococcus spp. (29% vs 12%, P = 0.003). Multivariate analysis showed that a PVPG greater than 5 mm Hg (odds ratio, 2.55; 95% confidence interval, 1.18-5.55; P = 0.017) was an independent predictor of bacteremia due to gut bacteria.
Monitoring of the PVPG is clinically meaningful for predicting patients' prognosis. In particular, a high PVPG with a threshold of 5 mm Hg at the end of adult-to-adult living donor liver transplantation may increase gut-related bacteremia through the mechanism of bacterial translocation, resulting in early mortality.
门静脉高压症(PHT)定义为门静脉压力梯度(PVPG)超过 5 毫米汞柱,导致严重的临床症状。然而,术中 PVPG 监测的有效性以及肝移植后 PHT 与细菌易位之间的关系尚不清楚。
在这项回顾性研究中,根据手术结束时的 PVPG 将 2008 年至 2015 年期间接受成人对成人活体供肝移植的 223 名患者分为 2 组:高 PVPG(>5 毫米汞柱,n=69)和低 PVPG(≤5 毫米汞柱,n=154)。比较两组之间的临床因素,并探讨高 PVPG 与移植后菌血症/细菌感染的关系。
高 PVPG 组菌血症的发生率(46%比 24%,P<0.001)、90 天死亡率(20%比 7%,P=0.002)和 1 年生存率(71%比 86%,P=0.006)均显著较高。高 PVPG 组更易发生“肠道细菌”引起的菌血症,包括肠杆菌科、拟杆菌属和肠球菌属(29%比 12%,P=0.003)。多变量分析显示,PVPG 大于 5 毫米汞柱(比值比,2.55;95%置信区间,1.18-5.55;P=0.017)是肠道细菌菌血症的独立预测因子。
PVPG 监测对预测患者预后具有临床意义。特别是,成人对成人活体供肝移植结束时 PVPG 阈值为 5 毫米汞柱可能通过细菌易位机制增加与肠道相关的菌血症,导致早期死亡率。